Thoughts on cardionephrology from the perspective of outpatient care
Abstract
Available clinical and pathophysiological evidence clearly demonstrates that the functions of the heart and the kidney are closely interconnected through a bidirectional and often self-perpetuating interaction. Because of this relationship, impairment of either organ can rapidly lead to deterioration of the other, ultimately resulting in a progressive and difficult-to-interrupt pathological cycle. Chronic kidney disease represents a significant cardiovascular risk factor even in its early stages, while cardiac abnormalities, both directly and indirectly, accelerate the decline in renal function. The clinical relevance of this interplay becomes particularly evident in the outpatient setting, where patient care is often fragmented and communication between specialties is insufficient. Based on these considerations, it is essential that collaboration between cardiology and nephrology becomes substantially closer, more direct, and better structured. An integrated approach between the two disciplines not only provides diagnostic advantages but also fundamentally influences therapeutic decisions and patient prognosis. At the practical level, this means that early and targeted assessment of cardiac status in patients with kidney disease, as well as regular and sensitive monitoring of renal function in cardiac patients, should not be considered optional but rather a fundamental requirement. Timely recognition and coordinated management of ardiorenal disorders can significantly reduce the risk of sudden cardiac death among patients with kidney disease and may slow or even prevent the deterioration of renal function in patients with heart failure. In summary, the cardiorenal approach is not merely a theoretical concept but a key element of everyday clinical practice. Its consistent application has the potential to substantially reduce cardiovascular mortality and to protect patients with heart disease from the development of end-stage renal failure.
References
Ronco C, Haapio M, House AA és mtsai: Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539. https://doi.org/10.1016/j.jacc.2008.07.051
KDIGO 2012: Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150.
Kraut JA, Madias NE: Metabolic acidosis of CKD: an update. Am J Kidney Dis 2016; 67: 307-317. https://doi.org/10.1053/j.ajkd.2015.08.028
Tattersall J, Martin-Malo A, Pedrini L és mtsai: EBPG guideline on dialysis strategies. Nephrol Dial Transplant 2007; 22(Suppl 2): ii5-21. https://doi.org/10.1093/ndt/gfm022
Timio M, Wizemann V: Cardionephrology: past, present and future. G Ital Nefrol 2014; 31: gin/31.5.12.
House AA, Wanner C, Sarnak MJ, és mtsai: Heart failure in chronic kidney disease: conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019; 95: 1304-1317.
Locatelli F, Hannedouche T, Martin-Malo A és mtsai: The Relationship of NT-proBNP and Dialysis Parameters with Outcome of Incident Haemodialysis Patients: Results from the Membrane Permeability Outcome Study Blood Purification 2013; 35: 216-223. https://doi.org/10.1159/000347076
McCullough PA, Ronco C, de Boer RA és mtsai: Cardiorenal syndrome: biomarkers linking kidney damage with heart failure. Heart Fail Rev 2011; 16: 615-625.
Rehman KA, Betancor J, Xu B és mtsai: Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology Clin Cardiol 2017; 40: 839-846. https://doi.org/10.1002/clc.22770
Reiss AB, Miyawaki N, Moon J és mtsai: CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Atherosclerosis 2018; 278: 49-59. https://doi.org/10.1016/j.atherosclerosis.2018.08.046
Copyright (c) 2026 Author

This work is licensed under a Creative Commons Attribution 4.0 International License.


